The relationship of blood pressure (BP; systolic, diastolic, pulse pressure, mean arterial pressure) in dialysis patients with diabetes is greatly complicated by competing risks and co-morbidities. Many studies failed...
Because of non-specific symptomatology, Fabry’s disease may elude diagnosis during progression of....
Novel urinary biomarkers for the early prediction of AKI in newly admitted patients to Intensive Care Units (ICU) have been developed but the overall clinical utility of these....
Calciphylaxis (Calcific Uremic Arteriopathy, CUA) is an uncommon but devastating and often fatal complication of...
The search for clinical, laboratory, and histological biomarkers useful for predicting outcomes in IgA nephropahy (IgAN) continues at a fairly rapid pace, but actual progress...
Viral-induced glomerular disease is a very important part of the spectrum of glomerulonephritis, especially since many...
Observational, long-term cohort studies can play an important role for generating testable hypotheses to improve our....
The “gold standard” for evaluation of urinary total protein excretion...
The treatment of membranous nephropathy (MN; PLA2R associated) has improved greatly in recent years, but uncertainties still exist concerning the treatment of such patients who have already advanced to stage 4...
Kidney fibrosis is one of the final common end-points of progressive CKD in both diabetic and non-diabetic patients. But very few studies have attempted to evaluate kidney fibrosis and its progression...
